|
|Section2= |Section6= |Section8= }} Pivagabine (Tonerg), also known as N-pivaloyl-γ-aminobutyric acid (N-pivaloyl-GABA), is an antidepressant and anxiolytic drug which was introduced in Italy in 1997 for the treatment of depressive and maladaptive syndromes. But it was discontinued in Italy (according to Martindale). Originally believed to function as a prodrug to GABA, pivagabine is now believed to act via inhibitory effects on corticotropin-releasing factor (CRF). ==See also== * Fengabine 抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Pivagabine」の詳細全文を読む スポンサード リンク
|